Nipt denied due to quantity / dose limits by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for nipt are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denied NIPT Under Quantity Limits

A quantity-limit denial for non-invasive prenatal testing (NIPT) typically means UHC's system flagged that the number of NIPT tests billed — or the number of NIPT results reported — exceeds what the coverage policy allows for a given pregnancy. Most NIPT coverage policies cover one test per pregnancy for an approved indication. A quantity-limit denial can arise if NIPT was ordered more than once (for example, due to a failed first draw, an inconclusive result requiring a redraw, a twin pregnancy requiring separate analysis, or a test ordered by a different provider in the same episode of care).

This type of denial is often reversible when the clinical reason for the additional test is documented. A redraw due to laboratory failure, an inconclusive or no-call result, or a clinically distinct new indication are among the grounds UHC's policy may recognize as exceptions.

## Federal Appeal Framework

• ACA §2719 external review: for fully insured non-grandfathered plans, independent external review is available after internal exhaustion. Check your denial letter for the exact filing deadline.
• ERISA §503: governs self-funded plans; internal appeal exhaustion is required.
• Expedited review: request if gestational timing creates urgency.

## Appeal Process and Timeline

1. Determine exactly which test encounter triggered the quantity-limit flag by reviewing the EOB and asking UHC to clarify which claim(s) were applied toward the limit. 2. Identify the clinical reason the additional test was ordered — laboratory failure, inconclusive result, clinician-initiated redraw, or other. 3. File a Level 1 internal appeal within the deadline on your denial notice, with a full clinical explanation and supporting documentation.

## Documentation to Gather

• Laboratory records: documentation from the testing laboratory of any failed draw, insufficient sample, inconclusive result, or no-call, and the laboratory's own recommendation to redraw.
• Clinical notes: the ordering clinician's chart entry explaining why a second (or additional) test was clinically indicated, including the date and circumstances of the repeat order.
• Ordering provider letter: explicitly addressing the quantity-limit denial, explaining the clinical necessity of the additional test, and confirming it was not duplicative of a valid prior result.
• Billing records: EOB and claim details confirming the dates of each test and each result to clarify the sequence of events.

## Criteria-Mapping Structure

Pull the quantity-limit provision and any stated exceptions from UHC's NIPT coverage policy. Create a table with each exception criterion in the left column and the chart/laboratory documentation supporting it in the right column. If UHC's policy does not explicitly list the exception that applies to your situation, cite the current professional society guidance (ACOG/SMFM) recognizing clinically appropriate repeat testing in your circumstances as support for a policy interpretation in your favor.